CCR Down Under 2025
Statement by Prof. Evangelos Giamarellos-Bourboulis on the Immunosep Trial
At CCR Down Under 2025, Prof. Evangelos Giamarellos-Bourboulis, Chief Investigator of the Immunosep trial, shares via Critical Care Reviews key findings and their significance for clinical practice.
Repost from the official Critical Care Reviews Instagram account.
Sepsis 2025
The pandemic “goes away” but the real pandemic is here:
This important webinar highlights sepsis as a persistent and serious global health challenge, far outlasting the COVID-19 pandemic. Hosted jointly by ISAC and the European Sepsis Alliance to mark World Sepsis Day, the event features two expert-led lectures:
• Dr Ricard Ferrer explores the role of biomarkers and molecular diagnostics in sepsis care, questioning their real-world impact on diagnosis and outcomes.
• Prof. Evangelos J. Giamarellos-Bourboulis discusses the concept of holistic patient management, examining whether such an approach truly exists and how it can be implemented effectively.
Together, these sessions aim to spark critical dialogue and drive innovation in the global fight against sepsis.
Moderators: Dr Michael David and Dr Sabiha Essack.
Educational activity
Microbiome Playlist
Recent Posts
Presentations & Interviews
A personalized immunotherapeutic approach to the treatment of sepsis: Evangelos Giamarellos, ECCMID 2023
The symposia ‘Sepsis – Biomarker-driven immunotherapy: it works.‘ (Symposia number: SY137) was presented at ECCMID 2023, 15-18 April, 2023, Copenhagen, Denmark.
Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
“Press conference of the results of SAVE-MORE trial” ERT Interview, September 2021
